The Effects of the Rivastigmine Patch on Attention and Behavior in Parkinson's Disease With Dementia (PDD).

Trial Profile

The Effects of the Rivastigmine Patch on Attention and Behavior in Parkinson's Disease With Dementia (PDD).

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Aug 2010 Planned end date changed from 1 Apr 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 03 Dec 2009 Actual end date (November 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top